Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dau-Ming Niu

Showing results (91-100 of 184) with videos related to

Pageof 19
Sort By:
Journal of Human Genetics|January 10, 2014
The mutation spectrum of the phenylalanine hydroxylase (PAH) gene and associated haplotypes reveal ethnic heterogeneity in the Taiwanese populationYing Liang, Miao-Zeng Huang, Cheng-Yi Cheng, et al.
Biochemical and Biophysical Research Communications|March 17, 2017
Amelioration of serum 8-OHdG level by enzyme replacement therapy in patients with Fabry cardiomyopathyKuan-Hsuan Chen, Yueh-Ching Chou, Chen-Yuan Hsiao, et al.
BMC Neurology|February 8, 2017
A comparison of central nervous system involvement in patients with classical Fabry disease or the later-onset subtype with the IVS4+919G>A mutationHan-Jui Lee, Ting-Rong Hsu, Sheng-Che Hung, et al.
Orphanet Journal of Rare Diseases|August 6, 2021
Hearing characteristics of infantile-onset Pompe disease after early enzyme-replacement therapyChien-Yu Hsueh, Chii-Yuan Huang, Chia-Feng Yang, et al.
Orphanet Journal of Rare Diseases|August 12, 2025
A multi-country time and motion study to describe the experience and burden associated with the treatment of Fabry disease with enzyme replacement therapy with agalsidase alfa and agalsidase betaIan Keyzor, Ana Maria Martins, Sema Kalkan Uçar, et al.
Pediatric Pulmonology|February 13, 2013
Characterization of pulmonary function impairments in patients with mucopolysaccharidoses--changes with age and treatmentShuan-Pei Lin, Shou-Chuan Shih, Chih-Kuang Chuang, et al.
Orphanet Journal of Rare Diseases|December 1, 2020
Audiological and otologic manifestations of glutaric aciduria type IYen-Chi Chen, Chii-Yuan Huang, Yen-Ting Lee, et al.
Diagnostics (Basel, Switzerland)|December 30, 2020
Aortic Root Dilatation in Taiwanese Patients with Mucopolysaccharidoses and the Long-Term Effects of Enzyme Replacement TherapyHsiang-Yu Lin, Ming-Ren Chen, Chung-Lin Lee, et al.
Molecular Genetics and Metabolism|March 6, 2014
Assessment of hearing loss by pure-tone audiometry in patients with mucopolysaccharidosesHsiang-Yu Lin, Shou-Chuan Shih, Chih-Kuang Chuang, et al.
European Heart Journal. Cardiovascular Imaging|October 23, 2021
Reduced global longitudinal strain as a marker for early detection of Fabry cardiomyopathyDai-Yin Lu, Wei-Ming Huang, Wei-Ting Wang, et al.
Pageof 19

Showing results (91-100 of 184) with videos related to

Sort By:
Pageof 19
Journal of Human Genetics|January 10, 2014
The mutation spectrum of the phenylalanine hydroxylase (PAH) gene and associated haplotypes reveal ethnic heterogeneity in the Taiwanese populationYing Liang, Miao-Zeng Huang, Cheng-Yi Cheng, et al.
Biochemical and Biophysical Research Communications|March 17, 2017
Amelioration of serum 8-OHdG level by enzyme replacement therapy in patients with Fabry cardiomyopathyKuan-Hsuan Chen, Yueh-Ching Chou, Chen-Yuan Hsiao, et al.
BMC Neurology|February 8, 2017
A comparison of central nervous system involvement in patients with classical Fabry disease or the later-onset subtype with the IVS4+919G>A mutationHan-Jui Lee, Ting-Rong Hsu, Sheng-Che Hung, et al.
Orphanet Journal of Rare Diseases|August 6, 2021
Hearing characteristics of infantile-onset Pompe disease after early enzyme-replacement therapyChien-Yu Hsueh, Chii-Yuan Huang, Chia-Feng Yang, et al.
Orphanet Journal of Rare Diseases|August 12, 2025
A multi-country time and motion study to describe the experience and burden associated with the treatment of Fabry disease with enzyme replacement therapy with agalsidase alfa and agalsidase betaIan Keyzor, Ana Maria Martins, Sema Kalkan Uçar, et al.
Pediatric Pulmonology|February 13, 2013
Characterization of pulmonary function impairments in patients with mucopolysaccharidoses--changes with age and treatmentShuan-Pei Lin, Shou-Chuan Shih, Chih-Kuang Chuang, et al.
Orphanet Journal of Rare Diseases|December 1, 2020
Audiological and otologic manifestations of glutaric aciduria type IYen-Chi Chen, Chii-Yuan Huang, Yen-Ting Lee, et al.
Diagnostics (Basel, Switzerland)|December 30, 2020
Aortic Root Dilatation in Taiwanese Patients with Mucopolysaccharidoses and the Long-Term Effects of Enzyme Replacement TherapyHsiang-Yu Lin, Ming-Ren Chen, Chung-Lin Lee, et al.
Molecular Genetics and Metabolism|March 6, 2014
Assessment of hearing loss by pure-tone audiometry in patients with mucopolysaccharidosesHsiang-Yu Lin, Shou-Chuan Shih, Chih-Kuang Chuang, et al.
European Heart Journal. Cardiovascular Imaging|October 23, 2021
Reduced global longitudinal strain as a marker for early detection of Fabry cardiomyopathyDai-Yin Lu, Wei-Ming Huang, Wei-Ting Wang, et al.
Pageof 19